查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1933890

全球医药级水市场（按产品类型、生产流程、最终用户和应用划分）预测（2026-2032）

Pharmaceutical Grade Water Market by Product Type, Manufacturing Process, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医药级水市场价值将达到 48.9 亿美元，到 2026 年将成长至 52.2 亿美元，到 2032 年将达到 81.2 亿美元，年复合成长率为 7.51%。

关键市场统计数据
基准年 2025 48.9亿美元
预计年份：2026年 52.2亿美元
预测年份 2032 81.2亿美元
复合年增长率 (%) 7.51%

在日益增长的技术和监管压力下，了解高纯度水在现代製药生产和临床环境中的关键作用

药用级水处于监管审查、生产可靠性和病人安全三者交汇点，是众多治疗和临床流程中不可或缺的基础组成部分。膜技术的最新进展、生物製药生产日益复杂的过程以及临床环境中不断强化的卫生通讯协定，都提升了水系统运作的重要性，并迫使各机构重新思考其设计、验证和维护模式。

技术创新、更严格的监管和不断发展的生产方法如何融合，将重新定义製药用水系统的战略重点

製药级水产业正经历着变革性的转变，其驱动力包括技术的整合、日益严格的监管以及製造地的转变。逆渗透和超过滤等膜技术正与先进的监测和自动化工具相结合，以实现即时品质保证和预测性维护，从而减少非计划性停机时间。同时，製程团队正在重新评估传统的蒸馏系统，转而采用兼顾稳健性和能源效率的混合解决方案。

评估2025年关税调整对製药用水处理设备及零件供应链的多面向营运与采购影响

2025年关税调整对水处理系统采购、资本设备购买和零件采购都产生了实际的影响。部分进口零件关税的提高促使工程团队重新评估供应商选择策略，并加快关键零件的在地采购，以确保进度和成本的可预测性。一些製造商已修订采购计划并调整材料清单（BOM），以降低关税波动带来的风险。

揭示水处理系统在产品类型、最终用户、应用和製造流程等方面的细微细分动态，从而推动技术和商业性差异化。

细分市场分析揭示了技术、使用者、应用和製程领域中不同的细分市场，这些细分市场影响着产品选择、检验复杂性和生命週期成本。依产品类型划分，市场分析涵盖纯净水、注射无菌水、血液透析用水和注射用水。纯净水再细分为去离子、蒸馏、逆渗透和超过滤。蒸馏技术本身分析了其间歇式和连续式两种变体，而逆渗透则分析了中空纤维和螺旋型。注射用水进一步细分为蒸馏技术和薄膜技术，其中薄膜技术透过超过滤进行探讨。

美洲、欧洲、中东和非洲以及亚太地区的区域战略差异和营运重点将影响製药用水解决方案的采用和部署。

区域趋势要求在实施、合规和供应商合作方面采取差异化的方法。美洲地区正集中投资于现有设施的现代化改造和数位化监控，因为监管要求和大规模生物製药製造地推动了严格的验证框架和高运转率标准的製定。该地区的投资趋势倾向于优先考虑远端监控和预测性维护的集成，以保障连续生产线和高价值药物的生产。

竞争格局分析揭示了产品整合、服务品质和数数位化准备如何使领先的水系统供应商与利基市场和新兴企业区分开来。

主要企业的发展趋势表明，竞争格局由产品线的广度、监管专业知识、服务网络和工程能力共同塑造。领先的系统供应商透过提供集水生产、分配、监控和全生命週期支援于一体的整合解决方案脱颖而出，帮助客户加快验证速度并降低整体拥有成本。拥有强大的全球服务网路和区域技术团队的公司，能够透过统一的合格文件和快速的现场回应，更好地为跨国客户提供支援。

为製造商和供应商提供一条切实可行的途径，以加快水系统检验和运作，同时增强合规性、韧性和成本控制。

产业领导者应优先采取一系列策略行动，在合规性、韧性和成本效益之间取得平衡，以应对不断变化的环境。首先，采用模组化系统结构和检验的替代筹资策略，以维持验证的连续性，同时降低供应链中断和关税带来的成本压力。其次，投资于自动化监控、资料完整性框架和预测性维护计划，以提高运作并满足生命週期品质预期，同时避免过多的人工干预。

采用稳健的混合方法研究途径，结合从业人员访谈、规范分析和资料三角验证，以检验有关製药用水系统的研究结果。

本研究采用多层次调查方法，结合了业界从业人员的初步研究及技术标准、法规指南及同侪审查文献的二次蒐集。初步研究包括对製程工程师、品质保证人员、采购经理和外部验证专家进行结构化访谈，并辅以对水生产和分配系统的现场观察，以了解运作限制。二次研究则利用法规文件、标准机构指南、技术白皮书和已发表的案例研究，为技术选择和合规性解读提供背景资讯。

整合策略和营运重点，揭示技术选择和组织协调如何决定製药用水系统专案的成功。

总之，对于寻求满足日益增长的品质要求和营运需求的製造商和临床试验机构而言，药用级水既是技术基础，也是战略槓桿。从去离子和逆渗透配置到蒸馏结构和超过滤滤膜，技术选择直接影响验证的复杂性、维护方案和能耗情况。同时，最终使用者的特性决定了可接受的冗余度、文件记录和服务需求。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的药用级水市场

  • 纯净水
    • 去离子
    • 蒸馏
      • 间歇蒸馏
      • 连续蒸馏
    • 逆渗透
      • 中空纤维膜
      • 螺旋缠绕式
    • 超过滤
  • 注射用无菌水
  • 血液透析用水
  • 注射用水
    • 蒸馏
    • 膜技术

9. 按生产流程分類的药用级水市场

  • 去离子
  • 蒸馏
    • 间歇蒸馏
    • 连续蒸馏
  • 逆渗透
    • 高压
    • 低压
  • 超过滤

第十章：依最终用户分類的医药级水市场

  • 合约研究机构
  • 医院和诊所
  • 製药生产
    • 生技公司
    • 学名药生产商
    • 大型製药企业

第十一章 按应用领域分類的医药级水市场

  • 设备清洁
  • 仅供实验室使用
  • 注射液
    • 静脉输液
      • 大容量配方
      • 小容量输液
    • 清洁液
  • 无菌包装

第十二章：各地区医药级水市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 医药级水市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国医药级水市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国药用级水市场

第十六章：中国医药级水市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aquafilsep
  • Aquatech International LLC
  • AQUAVISTA
  • Aqua-Chem, Inc.
  • Asahi Kasei Corporation
  • AWS Bio Pharma Technologies
  • Biocell Pharma
  • Biopuremax
  • BWT Group
  • CHIWATEC
  • Ecolab Inc.
  • Evoqua Water Technologies LLC
  • Fabtech
  • GEA Group Aktiengesellschaft
  • GT Metal & Process
  • Hydropure Systems
  • Kurita Water Industries Ltd.
  • LIVAM
  • MECO
  • Meissner Filtration Products, Inc.
  • Paragon Pharmaceutical Equipment Co., Ltd.
  • Parker Hannifin Corporation
  • Pharmalab India
  • Pure Aqua, Inc.
  • SUEZ SA
  • SUNCOMBE Ltd.
  • Tianjin Chaotuo Medical Equipment
  • Veolia Environnement SA
  • WEMAC Pharma Systems
  • Xylem Inc.
Product Code: MRR-C36616F699A8

The Pharmaceutical Grade Water Market was valued at USD 4.89 billion in 2025 and is projected to grow to USD 5.22 billion in 2026, with a CAGR of 7.51%, reaching USD 8.12 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.89 billion
Estimated Year [2026] USD 5.22 billion
Forecast Year [2032] USD 8.12 billion
CAGR (%) 7.51%

Framing the critical role of high-purity water in modern pharmaceutical operations and clinical environments amid evolving technical and regulatory pressures

Pharmaceutical grade water sits at the intersection of regulatory scrutiny, manufacturing reliability, and patient safety, making it a foundational input for a wide range of therapeutic and clinical processes. Recent advances in membrane technologies, growing complexity of biologics manufacturing, and heightened sanitation protocols across clinical settings have all elevated the operational importance of water systems, driving facilities to reassess design, validation, and maintenance paradigms.

Consequently, stakeholders across the value chain-from process engineers and quality assurance leads to procurement and clinical operations-must navigate evolving compliance expectations while optimizing for uptime and cost efficiency. This introduction establishes the imperatives that underpin subsequent sections: regulatory convergence, technology adoption, supply chain friction, and the strategic choices organizations face when designing or upgrading water systems for pharmaceutical and clinical applications.

How converging technological advances, regulatory tightening, and evolving manufacturing modalities are redefining strategic priorities for pharmaceutical water systems

The landscape for pharmaceutical grade water is undergoing transformative shifts driven by technology convergence, regulatory tightening, and shifting manufacturing footprints. Membrane technologies such as reverse osmosis and ultrafiltration are being integrated with advanced monitoring and automation tools, enabling real-time quality assurance and predictive maintenance that reduce unplanned downtime. Simultaneously, process teams are reevaluating legacy distillation systems in favor of hybrid solutions that balance robustness with energy efficiency.

These technological movements are accompanied by regulatory and GMP interpretive changes that emphasize lifecycle quality management and data integrity for water distribution and production systems. As organizations pursue biologics, personalized medicine, and higher-mix manufacturing, water systems must adapt to broader contamination risk profiles, necessitating investments in validation protocols, sensor networks, and trained personnel. Taken together, these forces are reshaping capital planning, supplier relationships, and operational frameworks across the industry.

Assessing the multifaceted operational and sourcing consequences of 2025 tariff adjustments on pharmaceutical water treatment equipment and component supply chains

Tariff changes implemented in 2025 have created tangible effects across procurement, capital equipment acquisition, and component sourcing for water treatment systems. Increased duties on specific imported components have prompted engineering teams to re-evaluate supplier qualification strategies and accelerate localization of critical elements to preserve schedule certainty and cost predictability. In some cases, manufacturers have shifted procurement timelines or restructured bills of materials to mitigate exposure to tariff volatility.

Beyond immediate cost impacts, tariffs have catalyzed secondary strategic adaptations: OEMs and systems integrators are emphasizing modular designs that allow higher proportions of locally sourced subsystems, while maintenance and spares inventories have been revisited to reduce lead-time risks. Regulatory documentation and qualification plans have been updated to reflect alternate suppliers and validated replacements, reinforcing the need for robust change-control processes. The net effect is a more resilient, though operationally complex, sourcing posture across water system lifecycles.

Uncovering nuanced segmentation dynamics across product type, end user, application, and manufacturing process that drive technical and commercial differentiation in water systems

Segmentation analysis reveals distinct technology, user, application, and process niches that shape product selection, validation complexity, and lifecycle costs. Based on product type, the market is studied across Purified Water, Sterile Water For Injection, Water For Hemodialysis, and Water For Injection, where Purified Water is further examined across Deionization, Distillation, Reverse Osmosis, and Ultrafiltration; Distillation itself is analyzed through Batch Distillation and Continuous Distillation variations, while Reverse Osmosis is considered in Hollow Fiber and Spiral Wound configurations, and Water For Injection is further differentiated between Distillation and Membrane Technology with Membrane Technology explored via Ultrafiltration.

From an end-user perspective, the market segmentation recognizes Contract Research Organizations, Hospital & Clinics, and Pharmaceutical Manufacturing, with the latter further dissected into Biotechnology Firms, Generic Pharma, and Large Pharma to reflect divergent validation stringency, volume throughput, and capital tolerance. Application-driven segmentation spans Equipment Cleaning, Laboratory Use, Parenteral Solutions, and Sterile Packaging, with Parenteral Solutions subdivided into Intravenous Solutions and Irrigation Solutions and Intravenous Solutions further separated into Large Volume Solutions and Small Volume Solutions, underscoring distinct purity and endotoxin control requirements. Manufacturing process segmentation mirrors product-level differentiation through Deionization, Distillation, Reverse Osmosis, and Ultrafiltration, while granular process variants such as Batch versus Continuous Distillation and High Pressure versus Low Pressure Reverse Osmosis indicate different engineering trade-offs for energy, footprint, and redundancy. These layered segmentation lenses illuminate how choices in one domain-such as opting for ultrafiltration versus distillation for Water For Injection-cascade into validation protocols, operational staffing, and maintenance frequencies across use cases.

Regional strategic distinctions and operational priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption and deployment of pharmaceutical water solutions

Regional dynamics require a differentiated approach to deployment, compliance, and supplier engagement. The Americas exhibit concentrated investment in modernization and digital monitoring for installed assets, where regulatory expectations and large-scale biologics manufacturing hubs push toward rigorous validation frameworks and high uptime standards. Investment trends in this region often prioritize integration of remote monitoring and predictive maintenance to protect continuous manufacturing lines and high-value drug production.

Europe, Middle East & Africa present a heterogeneous landscape where mature regulatory regimes coexist with emerging markets that emphasize scalable, cost-effective solutions. Here, legacy distillation systems remain prevalent in certain markets while advanced membrane adoption grows in regions prioritizing sustainability and footprint reduction. Asia-Pacific features rapid expansion of manufacturing capacity and a pronounced appetite for modular, scalable systems that support contract manufacturing and regional biotech growth, with localized manufacturing and supplier networks evolving to meet demand while also navigating regional regulatory harmonization efforts.

Competitive landscape analysis highlighting how product integration, service excellence, and digital enablement separate leading water systems providers from niche and emerging players

Key company dynamics point to a competitive environment shaped by product breadth, regulatory expertise, service networks, and engineering capabilities. Leading system providers differentiate themselves through integrated solutions that combine water generation, distribution, monitoring, and lifecycle support, enabling clients to accelerate validation and reduce total cost of ownership. Companies with strong global service footprints and regional technical teams are better positioned to support multinational customers through harmonized qualification documentation and rapid field response.

Innovative firms are investing in digital platforms that unify equipment telemetry, electronic batch records, and preventive maintenance scheduling, thereby creating recurring service revenue opportunities. Partnerships between equipment specialists and validation consultancies are also becoming more common as end users seek turnkey delivery of water systems that meet stringent GMP expectations. New entrants and niche players focus on specialized membrane approaches, energy-efficient distillation variants, or compact systems tailored for small-scale clinical manufacturing, intensifying competition while expanding choice for facility designers and quality teams.

Actionable pathways for manufacturers and providers to strengthen compliance, resilience, and cost control while accelerating validation and operational uptime in water systems

Industry leaders should prioritize a sequence of strategic actions that balance compliance, resilience, and cost efficiency to navigate the evolving landscape. First, adopt modular system architectures and validated alternate sourcing strategies to reduce vulnerability to supply chain disruptions and tariff-driven cost pressures while maintaining validation continuity. Second, invest in automated monitoring, data integrity frameworks, and predictive maintenance programs to enhance uptime and satisfy lifecycle quality expectations without imposing excessive manual oversight.

Third, align procurement and engineering decisions with application-specific purity requirements, recognizing that solutions optimized for equipment cleaning or laboratory use differ materially from those required for parenteral or Water For Injection applications. Fourth, cultivate deeper collaborations with validated service partners and regional technical teams to compress response times and streamline change-control processes. By sequencing these actions and embedding them into capital planning and quality roadmaps, organizations can improve resilience, manage operating cost, and accelerate time to productive operation.

Robust mixed-method research approach combining practitioner interviews, standards analysis, and data triangulation to validate insights on pharmaceutical water systems

The research methodology applies a multi-layered approach combining primary engagement with industry practitioners and secondary compilation of technical standards, regulatory guidance, and peer-reviewed literature. Primary inputs include structured interviews with process engineers, quality assurance leads, procurement managers, and external validation experts, complemented by site-level observations of water generation and distribution systems to understand real-world operational constraints. Secondary research leverages regulatory documents, standards bodies' guidance, technical white papers, and published case studies to contextualize technological choices and compliance interpretations.

Data triangulation is achieved by cross-referencing interview findings with documented validation records and system performance metrics where available, and by validating key assertions through follow-up consultations with independent experts. The methodology emphasizes transparency around assumptions and limitation statements, and it applies conservative interpretation of qualitative inputs to reduce bias. Where applicable, methodological steps to ensure reproducibility include audit trails of interview protocols, documented criteria for source selection, and version control for any analytical models used in synthesizing findings.

Synthesis of strategic and operational imperatives highlighting how technical choices and organizational alignment define successful pharmaceutical water system programs

In conclusion, pharmaceutical grade water represents both a technical backbone and a strategic lever for manufacturers and clinical operators aiming to meet rising quality expectations and operational demands. Technology choices-from deionization and reverse osmosis configurations to distillation architectures and ultrafiltration membranes-directly influence validation complexity, maintenance regimes, and energy profiles, while end-user distinctions shape acceptable redundancy, documentation, and service needs.

Moving forward requires a coordinated approach that blends modern monitoring and automation with resilient sourcing strategies and application-specific engineering. Organizations that proactively align capital investment, quality systems, and supplier strategies will be better positioned to manage regulatory scrutiny, reduce downtime risk, and support the increasingly sophisticated production and clinical paradigms that define contemporary pharmaceutical operations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Grade Water Market, by Product Type

  • 8.1. Purified Water
    • 8.1.1. Deionization
    • 8.1.2. Distillation
      • 8.1.2.1. Batch Distillation
      • 8.1.2.2. Continuous Distillation
    • 8.1.3. Reverse Osmosis
      • 8.1.3.1. Hollow Fiber
      • 8.1.3.2. Spiral Wound
    • 8.1.4. Ultrafiltration
  • 8.2. Sterile Water For Injection
  • 8.3. Water For Hemodialysis
  • 8.4. Water For Injection
    • 8.4.1. Distillation
    • 8.4.2. Membrane Technology

9. Pharmaceutical Grade Water Market, by Manufacturing Process

  • 9.1. Deionization
  • 9.2. Distillation
    • 9.2.1. Batch Distillation
    • 9.2.2. Continuous Distillation
  • 9.3. Reverse Osmosis
    • 9.3.1. High Pressure
    • 9.3.2. Low Pressure
  • 9.4. Ultrafiltration

10. Pharmaceutical Grade Water Market, by End User

  • 10.1. Contract Research Organizations
  • 10.2. Hospital & Clinics
  • 10.3. Pharmaceutical Manufacturing
    • 10.3.1. Biotechnology Firms
    • 10.3.2. Generic Pharma
    • 10.3.3. Large Pharma

11. Pharmaceutical Grade Water Market, by Application

  • 11.1. Equipment Cleaning
  • 11.2. Laboratory Use
  • 11.3. Parenteral Solutions
    • 11.3.1. Intravenous Solutions
      • 11.3.1.1. Large Volume Solutions
      • 11.3.1.2. Small Volume Solutions
    • 11.3.2. Irrigation Solutions
  • 11.4. Sterile Packaging

12. Pharmaceutical Grade Water Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Pharmaceutical Grade Water Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Pharmaceutical Grade Water Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Pharmaceutical Grade Water Market

16. China Pharmaceutical Grade Water Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aquafilsep
  • 17.6. Aquatech International LLC
  • 17.7. AQUAVISTA
  • 17.8. Aqua-Chem, Inc.
  • 17.9. Asahi Kasei Corporation
  • 17.10. AWS Bio Pharma Technologies
  • 17.11. Biocell Pharma
  • 17.12. Biopuremax
  • 17.13. BWT Group
  • 17.14. CHIWATEC
  • 17.15. Ecolab Inc.
  • 17.16. Evoqua Water Technologies LLC
  • 17.17. Fabtech
  • 17.18. GEA Group Aktiengesellschaft
  • 17.19. GT Metal & Process
  • 17.20. Hydropure Systems
  • 17.21. Kurita Water Industries Ltd.
  • 17.22. LIVAM
  • 17.23. MECO
  • 17.24. Meissner Filtration Products, Inc.
  • 17.25. Paragon Pharmaceutical Equipment Co., Ltd.
  • 17.26. Parker Hannifin Corporation
  • 17.27. Pharmalab India
  • 17.28. Pure Aqua, Inc.
  • 17.29. SUEZ S.A.
  • 17.30. SUNCOMBE Ltd.
  • 17.31. Tianjin Chaotuo Medical Equipment
  • 17.32. Veolia Environnement S.A.
  • 17.33. WEMAC Pharma Systems
  • 17.34. Xylem Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL GRADE WATER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PHARMACEUTICAL GRADE WATER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PHARMACEUTICAL GRADE WATER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SPIRAL WOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SPIRAL WOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SPIRAL WOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE WATER FOR INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE WATER FOR INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE WATER FOR INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MEMBRANE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DEIONIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BATCH DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTINUOUS DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HIGH PRESSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HIGH PRESSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HIGH PRESSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LOW PRESSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LOW PRESSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LOW PRESSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOSPITAL & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY HOSPITAL & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GENERIC PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GENERIC PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY EQUIPMENT CLEANING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY EQUIPMENT CLEANING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY EQUIPMENT CLEANING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LABORATORY USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LABORATORY USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LABORATORY USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE VOLUME SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE VOLUME SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY LARGE VOLUME SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SMALL VOLUME SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SMALL VOLUME SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SMALL VOLUME SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY IRRIGATION SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY IRRIGATION SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY IRRIGATION SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY STERILE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL PHARMACEUTICAL GRADE WATER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 251. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 254. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 255. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 257. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 259. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 262. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PARENTERAL SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS PHARMACEUTICAL GRADE WATER MARKET SIZE, BY INTRAVENOUS SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 293. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY PURIFIED WATER, 2018-2032 (USD MILLION)
  • TABLE 296. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 297. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLION)
  • TABLE 298. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY WATER FOR INJECTION, 2018-2032 (USD MILLION)
  • TABLE 299. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 300. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY DISTILLATION, 2018-2032 (USD MILLION)
  • TABLE 301. G7 PHARMACEUTICAL GRADE WATER MARKET SIZE, BY REVERSE OSMOSIS, 2018-2032 (USD MILLIO